Global Imc LLC’s Krystal Biotech Inc Position
Does Global Imc LLC own Krystal Biotech Inc (KRYS)? Not currently — the last reported position was 29.0K shares worth $5M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$5M
Q3 2024
Shares
29.0K
% of Portfolio
+1.06%
Quarters Held
14
position exited
Position History KRYS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 29.0K | $5M | +1.06% |
| Q2 2024 | 28.8K | $5M | +1.19% |
| Q1 2024 | 28.8K | $5M | +1.19% |
| Q3 2023 | 29.5K | $3M | +0.93% |
| Q2 2023 | 35.2K | $4M | +1.21% |
| Q4 2022 | 21.6K | $2M | +0.44% |
| Q3 2022 | 21.6K | $2M | +0.40% |
| Q2 2022 | 21.6K | $1M | +0.35% |
| Q1 2022 | 22.0K | $1M | +0.27% |
| Q4 2021 | 22.0K | $2M | +0.27% |
| Q1 2020 | 30.1K | $1M | +0.76% |
| Q4 2019 | 30.1K | $2M | +0.67% |
| Q3 2019 | 41.3K | $1M | +0.70% |
| Q2 2019 | 33.1K | $1M | +0.57% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Global Imc LLC’s full portfolio or all institutional holders of KRYS.